ODDB.org: Open Drug Database

Home - 67351 - 01 - 002

Nucala 100 mg/mL, Injektionslösung in der Fertigspritze - 3 x 1

Swissmedic Key	67351002	Registration Holder	GlaxoSmithKline AG
Name	Nucala 100 mg/mL, Injektionslösung in der Fertigspritze	Date of registration	13.02.2020
		Introduction of Sequence	13.02.2020
ATC-Classification	Mepolizumab (R03DX09)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	03.04.50.	Show package size	3 x 1
Index Therapeuticus (Swissmedic)	03.04.50.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680673510025	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

mepolizumabum 100 mg, saccharum, dinatrii phosphas heptahydricus, acidum citricum monohydricum, polysorbatum 80 dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.0 ml.

Packungsbestandteile

Galenic Form

Injektionslösung in der Fertigspritze

Excipiens

Active Agent	Dose
Mepolizumabum	100mg / 1ml

BAG: Active Agent	Dose
Mepolizumabum	100 mg

Inactive agents
Citric Acid Monohydrate
Disodium Phosphate Heptahydrate
Polysorbatum 80 Dinatrii Edetas
Saccharum

Source

Data was imported : 04.10.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH